2nd Quarter - Report

MEHLMAN CONSULTING, INC. for WEDGEWOOD PHARMACY LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to animal drug compounding.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Issues related to animal drug compounding.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Fiscal Year 2022 Appropriations. Fiscal Year 2023 Appropriations.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.